Common bacteria, such as those that cause urinary tract infections and sexually transmitted infections, are becoming increasingly difficult to treat. Without effective antibiotics, even simple infections could become deadly, making medical procedures like surgery, chemotherapy, and dialysis too dangerous.

2.8 Million Antibiotic-Resistant Infections Occur in the U.S. Each Year.

More than 35,000 people die as a result.

What is driving the rise in multidrug-resistant superbugs? 

The more antibiotics are used, the less effective they become. Unnecessary and inappropriate use accelerates that process.

1 in 3

antibiotic prescriptions written in doctors’ offices, emergency rooms, and hospital-based clinics are unnecessary—this equals about 47 million prescriptions each year.

52%

Only about half of patients treated with antibiotics for common infections received the recommended antibiotic based on established prescribing guidelines.

The COVID-19 pandemic has intensified the superbug threat.

Early in the pandemic, antibiotics were often given to patients even though these drugs do not effectively treat viral illnesses.

15%

increase in infections and deaths from drug-resistant bacteria in the first year of the COVID-19 pandemic across the U.S.

What can be done to combat antibiotic-resistant bacteria?

Eliminate inappropriate use of these lifesaving drugs and address the complex economic barriers hindering the development of new treatment options for patients.

Together, these efforts will help save antibiotics and protect the health of patients today and for generations to come.

This article was previously published on pewtrusts.org and appears in this issue of Trust Magazine.

Advance Health & Well-Being How Data Leads to Better Decisions

Trend Magazine